1. θ-Defensins: Cyclic Peptides with Endless Potential: FIGURE 1
- Author
-
Michael E. Selsted, Robert I. Lehrer, and Alexander M. Cole
- Subjects
chemistry.chemical_classification ,Innate immune system ,integumentary system ,Pseudogene ,fungi ,Minireviews ,Peptide ,Cell Biology ,Biology ,medicine.disease_cause ,Peptides, Cyclic ,Biochemistry ,Virology ,Cyclic peptide ,Defensins ,chemistry ,RNA splicing ,Influenza A virus ,medicine ,Humans ,Peptide Biosynthesis ,Molecular Biology ,Biogenesis - Abstract
θ-Defensins, the only cyclic peptides of animal origin, have been isolated from the leukocytes of rhesus macaques and baboons. Their biogenesis is unusual because each peptide is an 18-residue chimera formed by the head-to-tail splicing of nonapeptides derived from two separate precursors. θ-Defensins have multiple arginines and a ladder-like tridisulfide array spanning their two antiparallel β-strands. Human θ-defensin genes contain a premature stop codon that prevents effective translation of the needed precursors; consequently, these peptides are not present in human leukocytes. Synthetic θ-defensins with sequences that correspond to those encoded within the human pseudogenes are called retrocyclins. Retrocyclin-1 inhibits the cellular entry of HIV-1, HSV, and influenza A virus. The rhesus θ-defensin RTD-1 protects mice from an experimental severe acute respiratory syndrome coronavirus infection, and retrocyclin-1 protects mice from infection by Bacillus anthracis spores. The small size, unique structure, and multiple host defense activities of θ-defensins make them intriguing potential therapeutic agents.
- Published
- 2012
- Full Text
- View/download PDF